Development asset linked to Shandong Topscience Biotech in public FDA and regional records.
pharma · Stroke · Pancreatic Cancer
Shandong Topscience Biotech
Shandong Suncadia Medicine Co.,
Shandong Topscience Biotech drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Rizhao, CN HQ
2005 Founded
15 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Rizhao, CN
- Founded
- 2005
- Employees
- 15
- Programs
- 3
- Drugs
- 4
- Patents
- 0
Shandong Topscience Biotech pipeline
Portfolio lens on 4 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Shandong Topscience Biotech drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Shandong Topscience Biotech in public FDA and regional records.
-
Development asset linked to Shandong Topscience Biotech in public FDA and regional records.
-
ulipristal acetate
Genito-urinary system and sex hormones (G03)US regulatory status: approved. Molecular target: Progesterone receptor.
- Target
- Progesterone receptor
- Mechanism
- Progesterone receptor modulator